618 matches for your search in the start-up spotlight
rss
We are a spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy. Fusix Biotech GmbH is a Munich based start-up founded in 2022. The management team is comprised of the four ...
Visienco is a Swiss techbio company on a mission to make organoids clinically reliable at scale. Organoids, lab-grown mini-organs, are transforming how we understand human biology and test therapies. But their full potential is limited by manual, variable, and low-throughput workflows. At ...
For growers who want to get the best yield without wasting resources, NutriSen has developed the first biosensors test strips that can measure the amount of nitrate in plants directly in the field. Instead of indirect measurements such as chlorophyll content, NutriSen provides lab-accurate ...
The TQx platform will transform the traditional way of producing cellular therapies, which is often slow, expensive, and hard to scale, into a very fast and highly automated process right at the patient's side. This method uses extra-corporeal gene therapy but keeps the benefits of autologous ...
ReproNovo was founded in 2021 by a team with proven expertise in the reproductive medicine and women’s health space. With years of immersion in this field, we possess deep knowledge of drug development, regulatory affairs and business development in these therapeutic areas, the treatment ...
Azafaros is a clinical-stage company founded in 2018 with a deep understanding of rare genetic disease mechanisms using compound discoveries made by scientists at Leiden University and Amsterdam UMC and is led by a team of highly experienced industry experts. Azafaros aims to build a pipeline of ...
We are here to change the rules of the game. Prove that it is possible to reinvent materials. Make them clean. Honest. Uncomplicated. To fight the climate crisis, it is necessary to fuse nature, technology and science. Revoltech is the result of this sum. Together, we are starting a sustainable ...
Paques Biomaterials develops a biodegradable alternative to plastic by using organic side streams. How do we do that? We developed a technology for microbes to produce a biopolymer (PHA) from organic residual streams. Our technology doesn’t modify bacteria genetically and we use no fossil ...
Paques Biomaterials develops a biodegradable alternative to plastic by using organic side streams. How do we do that? We developed a technology for microbes to produce a biopolymer (PHA) from organic residual streams. Our technology doesn’t modify bacteria genetically and we use no fossil ...
Granite Bio is a biotechnology company developing first-in-class antibodies that target the root causes of a variety of inflammatory, autoimmune and fibrotic conditions. Granite is backed by leading healthcare venture firms including Versant Ventures, Novartis Venture Fund, Forbion and Sanofi ...
